admin's picture

Retirement of Prof. Robert Allen

Retirement of Prof. Robert Allen

Prof. Allen has retired from practice and from other official duties.  We thank him for his years as clinical advisor to this company and to his invaluable help and assistance.

admin's picture

Vit D3 (cholecalciferol) and osteoporosis (risk of falls and fractures)

A recent report in JAMA (i) has highlighted a potential problem with very high dose oral cholecalciferol in elderly people - “A double-blind, placebo-controlled trial of 2256 community-dwelling women, aged 70 years or older, considered to be at high risk of fracture were recruited from June 2003 to June 2005 and were randomly assigned to receive cholecalciferol or placebo each autumn to winter for 3 to 5 years. The study concluded in 2008.”

The participants received a single oral dose of 500,000 IU of cholecalciferol or placebo.

admin's picture

Co-infusing Glutathione and Vitamin C during cancer treatment: a reply

Dettman I, Meakin C, Allen R; Co-infusing Glutathione and Vitamin C during cancer treatment: A reply. ACNEM Journal, Mar 2012, Vol 31 No. 1 p 8-11

admin's picture

Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

This article is a great review of the author's understanding of the role of adjunctive treatments at end of life.

Ichim TE, Minev B, Braciak T, Luna B, Hunninghake R, Mikirova NA, Jackson JA, Gonzalez MJ, Miranda Massari JR, Alexandrescu DT, Dasanu C, Bogin V, Ancans J, Stevens RB, Markosian B, Koropatnick J, Chen CS, Riordan NH. Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? J Transl Med. 2011 Mar 4;9(1):25. [Epub ahead of print] PubMed PMID: 21375761

admin's picture

Attending Japanese College of Intravenous Therapy 2010 - a great success

The Japanese College of Intravenous Therapy, headed by Dr Atsuo Yanagisawa, recently held a meeting for Doctors on the topic of “Intravenous Vitamin C and Cancer”. Several notable Japanese and o/seas researchers presented some leading edge research – included Dr Steve Hickey author of “Ascorbate –the science of Vitamin C” who was accompanied by the co-author Dr Hilary Roberts, Dr Ron Hunninghake leading researcher at the Riordan Clinic and Dr John Hoffer (Dr Abram Hoffers’s son) also a leading researcher in IVC and cancer.

admin's picture

Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: RCT


An increased rate of brain atrophy is often observed in older subjects, in particular those who suffer from cognitive decline. Homocysteine is a risk factor for brain atrophy, cognitive impairment and dementia. Plasma concentrations of homocysteine can be lowered by dietary administration of B vitamins.


admin's picture

Pharmacological ascorbic acid suppresses syngeneic tumor growth and metastases in hormone-refractory prostate cancer



The aim of this study was to test for the influence of ascorbic acid on tumorigenicity and metastases of implanted PAIII prostate cancer adenocarcinoma cells in syngeneic LW rats. 


admin's picture

Farmer with Swine Flu and pneumonia recovers after high dose IVC

The following is a link to the NZ TV program about the farmer who recovered from swine flu becuase the doctors in the hospital turned him into a prone position (and he was incidentally on high-dose IV C):


admin's picture

Effect of B-Vitamin Therapy on Progression of Diabetic Nephropathy: A Randomized Controlled Trial

A recent report AGAIN in JAMA (i) has highlighted a potential problem with very high dose oral folate along with B6 and B12 in people with diabetic nephropathy -  “A multicenter, randomized, double-blind, placebo controlled trial (Diabetic Intervention with Vitamins to Improve Nephropathy [DIVINe]) at 5 university medical centers in Canada conducted between May 2001 and July 2007 of 238 participants who had type 1 or 2 diabetes and a clinical diagnosis of diabetic nephropathy.”

Patients in the trial were followed for up to 3 years AFTER the folate and B6 and B12 were stopped.